CIDRAP newsletters options
COVID-19 patients had 4 times the risk of mechanical ventilation and double the risk of ICU care.
COVID-19 cases, hospitalizations, and deaths in the US continue to climb.
Experts estimate that nearly a fourth of the world's people may not have access to a vaccine till at least 2022.
Sales of medically important antibiotics for food animals rise 3% from 2018 to 2019, following a 9% increase the year before.
About 2 in 10 US school districts have said they will continue, or are considering continuing, distance learning after the COVID-19 pandemic ends, citing student and parent demand, according to a Rand Corporation study released yesterday.
Data show the vaccine protects against severe disease and may protect against asymptomatic infections, too.
Officials noted more than 4.3 million new global infections in the past week, a 4% increase.
Maximizing vaccine uptake includes setting examples, effective messaging, and apps to encourage the 2nd dose.
Investigators with the United Kingdom's RECOVERY trial reported yesterday that a preliminary analysis of data from the azithromycin arm of the trial showed the antibiotic had no impact on clinical outcomes in hospitalized COVID-19 patients.
A sample from a white-tailed deer in Wyandot County, Ohio, tested positive for chronic wasting disease (CWD) Dec 10, according to the Ohio Department of Natural Resources (ODNR) yesterday, the first in a wild deer in the state.
Vaccine arrived at 145 centers today, and 425 sites will get deliveries tomorrow.
A large UK epidemiologic study finds no association with GBS, which has been a concern.
Other regions considering further measures include London, Germany, Italy, and the Netherlands.
Political affiliation appears to have more impact than local disease spread in 2 new studies.
Data published late last week in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) detailed public school costs for recommended COVID-19 mitigation strategies, which averaged $442 per student but varied widely.
Emergency approval makes the vaccine available and offers hope for altering the course of the pandemic.
The step allows health workers to begin giving the vaccine and offers guidance on immunization policy.
One study points to the use of certain medications, and the other shows elevated risk in non-white populations.
Pressure over emergency use approval raises worries that the process has been rushed.
Studies show a 57% higher COVID-19 hospital rate for gynecologic cancer and a 29% higher rate for all cancers in black patients.
